Clinical Outcomes in Stage III Non-Small Cell Lung Cancer Patients Treated With Durvalumab After Sequential or Concurrent Platinum-Based Chemoradiotherapy – Single Institute Experience. Radiol Oncol 2021, 55 (4), 482-490.